|
|
|
On this week's episode of the Business of Biotech, Brian Hilberdink, President of U.S. Human Pharma at Boehringer Ingelheim, returns to the show during the J.P. Morgan Healthcare Conference, following his departure from LEO Pharma. |
|
|
|
|
| NextGen Biomed 2026 brings together senior scientific and strategic leaders across proteins & antibodies, peptides & oligonucleotides, immunotherapy, vaccines, and next-generation modalities. Gain real-world insight, practical case studies, and proven strategies to accelerate discovery, development, and scale-up. Plus: network and unwind at the Comedy Night with Simon Brodkin. London | 24–25 March 2026 | Join us. |
|
|
|
| Proven Interchangeability Assessment Strategies | Struggling with single‑use component changes? Discover a clear, risk‑based framework — plus supplier insights and ready‑to-use tools—to strengthen compliance and boost biomanufacturing resilience. |
|
|
|
|
|
|
| Where Precision Meets Personal Connection | Robert Lohayza, a Certified Mobile Research Nurse (CMRN), shares his experience and underscores the essential role of mobile clinicians in advancing global clinical research. |
|
|
